Paul Tudor Jones’s Cincinnati Financial CINF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,041
Closed -$3.82M 3638
2026
Q1
$3.63M Buy
+23,041
New +$3.75M 0.01% 1405
2023
Q3
Sell
-89,303
Closed -$8.69M 2350
2023
Q2
$8.69M Buy
89,303
+85,650
+2,345% +$8.85M 0.1% 222
2023
Q1
$409K Sell
3,653
-30,158
-89% -$3.43M 0.01% 1735
2022
Q4
$3.46M Buy
33,811
+2,022
+6% +$208K 0.07% 364
2022
Q3
$2.85M Buy
+31,789
New +$3.27M 0.06% 403
2021
Q1
Sell
-5,300
Closed -$463K 1589
2020
Q4
$463K Sell
5,300
-637
-11% -$50.8K 0.01% 980
2020
Q3
$463K Buy
+5,937
New +$460K 0.02% 846
2018
Q1
Sell
-4,310
Closed -$323K 1024
2017
Q4
$323K Buy
+4,310
New +$321K 0.01% 780
2016
Q4
Sell
-2,900
Closed -$219K 1418
2016
Q3
$219K Buy
+2,900
New +$220K 0.01% 1211
2016
Q2
Sell
-4,900
Closed -$320K 1652
2016
Q1
$320K Buy
4,900
+1,400
+40% +$85.2K 0.01% 1253
2015
Q4
$207K Sell
3,500
-2,400
-41% -$142K 0.01% 1429
2015
Q3
$317K Buy
+5,900
New +$317K 0.01% 1064
2013
Q3
Sell
-5,000
Closed -$230K 827
2013
Q2
$230K Buy
+5,000
New +$238K 0.02% 679

Other funds holding CINF

Paul Tudor Jones's CINF Position: Q2 2026 in Review

Paul Tudor Jones sold out of Cincinnati Financial (CINF) in Q2 2026, closing a stake of 23,041 shares — an estimated $3.82M sold.

Paul Tudor Jones first reported a position in CINF in Q2 2013 and held it in 13 quarters. The position peaked at $8.69M in Q2 2023. 948 funds tracked by Wall St. Rank hold CINF as of Q2 2026.

  • Paul Tudor Jones reported no remaining Cincinnati Financial position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 23,041 Cincinnati Financial shares in Q2 2026, an estimated $3.82M.
  • Paul Tudor Jones first reported a position in Cincinnati Financial in Q2 2013 and held it in 13 quarters.
  • Paul Tudor Jones's Cincinnati Financial position peaked at $8.69M in Q2 2023.
  • 948 funds tracked by Wall St. Rank held Cincinnati Financial as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.